Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011–2014): a cross-sectional study
Abstract Background Although gabapentin has been licensed in the European Union only for neuropathic pain and epilepsy for patients who have partial seizures, it has also been prescribed in treatment for substance use disorders. Many studies report the potential risk of abuse of gabapentin by people...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-03-01
|
| Series: | Archives of Public Health |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13690-018-0254-8 |